Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

The information on this page is intended for news media in the European Union only.

September 5th, 2017

Cook Medical introduces Cellvizio® Confocal Laser Endomicroscopy System

Limerick, Ireland: Cook Medical’s Urology business announced that it will begin distributing the Cellvizio® Confocal Laser Endomicroscopy (CLE) System manufactured by Mauna Kea Technologies. With the Cellvizio system, a physician can visualise the internal microstructure of tissues in real time during ureteroscopic and cystoscopic procedures.

“We are excited to bring Cellvizio to urologists in Europe,” said Jean-Marc Creissel, vice president of Cook’s Urology business. “Allowing physicians to view tissue in real time offers them an opportunity to quickly determine potential options for patients.”

CLE is an endoscopic technique that incorporates laser scanning technology to generate images of the internal microstructure of tissues. Cellvizio is a probe-based CLE system that uses Confocal Miniprobes™, which are made up of optical fiber bundles and other optical elements. The probes transmit the laser energy to the tissue site and detect the fluorescent light that is reflected back. This reflected light is generated into real-time images of the internal microstructure of tissues.

The Cellvizio system is composed of various components that are placed on a portable cart. This setup allows the system to be transported between rooms in a hospital or clinic. The sterile probes used with the system can be reprocessed up to 20 times, depending on the model.

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on Twitter, Facebook and LinkedIn.